Show Abstract ▼

Abstract: Prion disease is caused by the misfolding of the cellular prion protein, PrPC, into a self-templating conformer, PrPSc. Nuclear magnetic resonance (NMR) and X-ray crystallography revealed the 3D structure of the globular domain of PrPC and the possibility of its dimerization via an interchain disulfide bridge that forms due to domain swap or by non-covalent association of two monomers. On the contrary, PrPSc is composed by a complex and heterogeneous ensemble of poorly defined conformations and quaternary arrangements that are related to different patterns of neurotoxicity. Targeting PrPC with molecules that stabilize the native conformation of its globular domain emerged as a promising approach to develop anti-prion therapies. One of the advantages of this approach is employing structure-based drug discovery methods to PrPC. Thus, it is essential to expand our structural knowledge about PrPC as much as possible to aid such drug discovery efforts. In this work, we report a crystallographic structure of the globular domain of human PrPC that shows a novel dimeric form and a novel oligomeric arrangement. We use molecular dynamics simulations to explore its structural dynamics and stability and discuss potential implications of these new quaternary structures to the conversion process.

Show Abstract ▼

Abstract: Ceria (cerium oxide) based materials have been widely used for catalytic applications including; fluid catalytic cracking, water gas shift reactions, solid oxide fuel cells and automotive catalytic after-treatment. It has often been the material of choice for supporting precious metals in many of the applications previously mentioned, as it can provide a high surface area and has excellent redox properties. This enables ceria to absorb oxygen into its structure and release it again, to facilitate oxidation reactions. Cerium is also one of the most abundant rare earth metals, making it a relatively cost effective material to use in industrial applications. For these reasons, cerium oxide remains to be a material of high interest for the development of cost-effective industrial catalysts and is, therefore, the focal material for this work. Modern internal combustion engine technology is being directed towards lean burn operation, involving higher air-fuel ratios in order to improve thermal efficiency. In turn, the operating temperature of modern engines is being reduced, providing less of the heat energy required to activate the catalysts in the after-treatment system. Therefore, in order to mitigate the emission from efficient lean burn engines and comply with emission regulations, the requirement for low temperature automotive catalysts is apparent. The objective of this work is to develop effective ceria based materials for the application of modern automotive after-treatment catalysis. The first approach is the use of a novel method for the preparation of a mixed oxide catalysts, which show high activity for CO and HC oxidation at low temperature. The preparation of ceria/manganese mixed oxide catalysts using a novel synthesis method has been studied and the materials were characterised to gain insights of their structure and morphology. Temperature programmed reactions using a complex mixture of reactants, before and after hydrothermal aging, were carried out to investigate their application for automotive emission control. The results from these studies were compared with more conventional ceria based materials that are often used for automotive after-treatment. A second approach used in this work is a post synthesis technique for the surface modification of ceria catalysts using ion bombardment. This technique was carried out on a commercially sourced, model catalyst. A Pt-CeO2/ZrO2 was treated with nitrogen ion irradiation and the effects of the adjustable parameters of the ion beam were investigated by carrying out temperature programmed reactions. The samples were also extensively characterised using XAFS and XPS techniques to understand the effects of the ion beam treatment on the structure, morphology and Pt dispersion of the materials.

Open Access

Show Abstract ▼

Abstract: An estimated half of all proteins contain a metal, with these being essential for a tremendous variety of biological functions. X-ray crystallography is the major method for obtaining structures at high resolution of these metalloproteins, but there are considerable challenges to obtain intact structures due to the effects of radiation damage. Serial crystallography offers the prospect of determining low-dose synchrotron or effectively damage free XFEL structures at room temperature and enables time-resolved or dose-resolved approaches. Complementary spectroscopic data can validate redox and or ligand states within metalloprotein crystals. In this opinion, we discuss developments in the application of serial crystallographic approaches to metalloproteins and comment on future directions.

Open Access

Show Abstract ▼

Abstract: A useful tool to analyze the ligands and/or environmental contribution to protein stability is represented by the Synchrotron Radiation Circular Dichroism UV-denaturation assay that consists in the acquisition of several consecutive repeated far-UV SRCD spectra. Recently we demonstrated that the prevailing mechanism of this denaturation involves the generation of free radicals and reactive oxygen species (ROS). In this work, we analyzed the effect of buffering agents commonly used in spectroscopic measurements, including MOPS (3-(N-morpholino) propanesulfonic acid), HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), TRIS-HCl (tris-hydroxymethil aminomethane hydrochloride), and phosphate, on the efficiency of protein denaturation caused by exposure to UV radiation. Fluorescence experiments confirmed the presence of ROS and were used to determine the rate of ROS generation. Our results indicate that the efficiency of the denaturation process is strongly influenced by the buffer composition with MOPS and HEPES acting also as scavengers and that the presence of proteins itself influenced the ROS formation rate.

Show Abstract ▼

Abstract: In this article we describe the identification of unprecedented ATP-competitive ChoKα inhibitors starting from initial hit NMS-P830 that binds to ChoKα in an ATP concentration-dependent manner. This result is confirmed by the co-crystal structure of NMS-P830 in complex with Δ75-ChoKα. NMS-P830 is able to inhibit ChoKα in cells resulting in the reduction of intracellular phosphocholine formation. A structure-based medicinal chemistry program resulted in the identification of selective compounds that have good biochemical activity, solubility and metabolic stability and are suitable for further optimization. The ChoKα inhibitors disclosed in this article demonstrate for the first time the possibility to inhibit ChoKα with ATP-competitive compounds.